When administered in combination with 5-fluorouracil, ginsenoside Rg3 can significantly increase the apoptosis rate in colon cancer (SW620 and LoVo) cells through the activation of the Apaf1/Caspase-9/Caspase-3 pathway [650]. This evidence concerns the gene CASP9 and malignant colon neoplasm.